Expand SANA Menu
SANA MENU

SANA Latest Press Releases

-- December 8, 2025 --

Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform Globe Newswire 9:00 AM

-- November 24, 2025 --

Sana Biotechnology to Present at December 2025 Investor Conferences Globe Newswire 4:05 PM

-- November 19, 2025 --

The Biotech Sector is Seeing a Major Boost From Programmable Cell Therapies in Chronic Disease Care Globe Newswire 10:06 AM

-- November 6, 2025 --

Sana Biotechnology Reports Third Quarter 2025 Financial Results and Business Updates Globe Newswire 4:05 PM

-- November 4, 2025 --

Sana Biotechnology to Present at the TD Cowen Immunology & Inflammation Summit Globe Newswire 4:05 PM

-- August 28, 2025 --

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies PRNewswire 8:00 AM

-- August 26, 2025 --

Sana Biotechnology to Present at September 2025 Investor Conferences Globe Newswire 4:05 PM

-- August 21, 2025 --

Biotechs Big Bang: IPOs, Uplists and the Short Squeeze Effect Yolowire 7:41 AM

-- August 20, 2025 --

Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares Globe Newswire 4:05 PM

-- August 11, 2025 --

Sana Biotechnology Reports Second Quarter 2025 Financial Results and Business Updates Globe Newswire 4:05 PM
Ajit Singh Appointed CEO of Harbinger Health and CEO-Partner of Flagship Pioneering PRNewswire 12:00 PM

-- August 6, 2025 --

Sana Biotechnology Announces Pricing of Public Offering Globe Newswire 11:24 PM
Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants Globe Newswire 4:38 PM
Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates Globe Newswire 7:00 AM

-- August 4, 2025 --

Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes Globe Newswire 11:35 AM
Market Data Delayed 15 Minutes